Efficient gene therapy based targeting system for the treatment of inoperable tumors

Journal of Gene Medicine

Volumn 14, Issue 4, 2012, Pages 221-230

  Wirth, Thomas ^a   Pikkarainen, Jere Tuomas ^a,c   Samaranayake, Haritha Dhammika ^a,c   Lehtolainen Dalkilic, Pauliina ^c   Lesch, Hanna Pirita ^a,c   Airenne, Kari Juhani ^a   Marjomäki, Varpu ^d   Ylä Herttuala, Seppo Pasi Antero ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Finland Ark Therapeutics Oy   (Finland)

^d UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

Brain cancer; Drug targeting; Gene therapy; Molecular imaging; Radiotherapy

Indexed keywords

AVIDIN; HORSERADISH PEROXIDASE; HYBRID PROTEIN; LENTIVIRUS VECTOR; YTTRIUM 90;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GLIOMA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO GENE TRANSFER; IN VIVO STUDY; INOPERABLE CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL; THERAPY EFFECT; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; AVIDIN; BIOTINYLATION; GENETIC THERAPY; GENETIC VECTORS; GLIOMA; LENTIVIRUS; MICE; MICE, NUDE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; RATS; RECEPTORS, LDL; RECOMBINANT FUSION PROTEINS; SEMLIKI FOREST VIRUS;

ANIMALIA; LENTIVIRUS; RATTUS; SEMLIKI FOREST VIRUS;

EID: 84859878691     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.2619     Document Type: Article

References (26)

1. Claes A, Idema AJ, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007; 114: 443-458.
2. Castro MG, Cowen R, Williamson IK, et al. Current and future strategies for the treatment of malignant brain tumours. Pharmacol Ther 2003; 98: 71-108.
3. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide vs. radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459-466.
4. Barbagallo GM, Jenkinson MD, Brodbelt AR. 'Recurrent' glioblastoma multiforme, when should we reoperate? Br J Neurosurg 2008; 22: 452-455.
5. Stark AM, Hedderich J, Held-Feindt J, Mehdorn HM. Glioblastoma - the consequences of advanced patient age on treatment and survival. Neurosurg Rev 2007; 30: 56-61.
6. Olkkonen VM, Dupree P, Simons K, Liljestrom P, Garoff H. Expression of exogenous proteins in mammalian cells with the Semliki Forest virus vector. Methods Cell Biol 1994; 43: 43-53.
7. Lesch HP, Pikkarainen JT, Kaikkonen MU, et al. Avidin fusion protein-expressing lentiviral vector for targeted drug delivery. Hum Gene Ther 2009; 20: 871-882.
8. Follenzi A, Naldini L. HIV-based vectors. Preparation and use. Methods Mol Med 2002; 69: 259-274.
9. Kappel A, Ronicke V, Damert A, Flamme I, Risau W, Breier G. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood 1999; 93: 4284-4292.
10. Lehtolainen P, Taskinen A, Laukkanen J, et al. Cloning and characterization of Scavidin, a fusion protein for the targeted delivery of biotinylated molecules. J Biol Chem 2002; 277: 8545-8550.
11. Kataoka H, Takakura N, Nishikawa S, et al. Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells. Dev Growth Differ 1997; 39: 729-740.
12. Mantyla T, Hakumaki JM, Huhtala T, Narvanen A, Yla-Herttuala S. Targeted magnetic resonance imaging of Scavidin-receptor in human umbilical vein endothelial cells in vitro. Magn Reson Med 2006; 55: 800-804.
13. Sandmair AM, Turunen M, Tyynela K, et al. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions. Cancer Gene Ther 2000; 7: 413-421.
14. Sohlberg A, Lensu S, Jolkkonen J, Tuomisto L, Ruotsalainen U, Kuikka JT. Improving the quality of small animal brain pinhole SPECT imaging by Bayesian reconstruction. Eur J Nucl Med Mol Imaging 2004; 31: 986-994.
15. Sohlberg A, Kuikka JT, Ruotsalainen U. Pinhole single-photon emission tomography reconstruction based on median root prior. Eur J Nucl Med Mol Imaging 2003; 30: 217-221.
16. Sohlberg A, Ruotsalainen U, Watabe H, Iida H, Kuikka JT. Accelerated median root prior reconstruction for pinhole single-photon emission tomography (SPET). Phys Med Biol 2003; 48: 1957-1969.
17. Paganelli G, Grana C, Chinol M, et al. Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur J Nucl Med 1999; 26: 348-357.
18. Tanimoto A, Oshio K, Suematsu M, Pouliquen D, Stark DD. Relaxation effects of clustered particles. J Magn Reson Imaging 2001; 14: 72-77.
19. Pardridge WM. Drug and gene delivery to the brain: the vascular route. Neuron 2002; 36: 555-558.
20. Goodwin DA, Meares CF. Advances in pretargeting biotechnology. Biotechnol Adv 2001; 19: 435-450.
21. Grana C, Chinol M, Robertson C, et al. Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study. Br J Cancer 2002; 86: 207-212.
22. Di Carlo V, De Nardi P, Stella M, Magnani P, Fazio F. Preoperative and intraoperative radioimmunodetection of cancer pretargeted by biotinylated monoclonal antibodies. Semin Surg Oncol 1998; 15: 235-238.
23. Paganelli G, Bartolomei M, Grana C, Ferrari M, Rocca P, Chinol M. Radioimmunotherapy of brain tumour. Neurol Res 2006; 28: 518-522.
24. Kassis AI, Jones PL, Matalka KZ, Adelstein SJ. Antibody-dependent signal amplification in tumour xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin. J Nucl Med 1996; 37: 343-352.
25. Tijink BM, Laeremans T, Budde M, et al. Improved tumour targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology. Mol Cancer Ther 2008; 7: 2288-2297.
26. Hudson PJ, Souriau C. Engineered antibodies. Nat Med 2003; 9: 129-134.